Condition: Glioblastoma · Brain Tumor · Cannabis · Sponsor: University of Birmingham
ARISTOCRAT is a phase II, multi-centre, double-blind, placebo-controlled, randomised trial to compare the cannabinoid Nabiximols with placebo in patients with recurrent MGMT methylated glioblastoma (GBM) treated with temozolomide (TMZ).
This description comes directly from the study's public registry record.
Rhys Mant · +441214146788 · aristocrat@trials.bham.ac.uk
Joshua Savage · j.savage.1@bham.ac.uk
Always discuss trial participation with your own doctor first.
| Glan Clwyd Hospital | Bodelwyddan, Denbighshire, United Kingdom | Withdrawn |
| Mount Vernon Hospital, The Hillingdon Hospitals NHS Foundation Trust | Northwood, Middlesex, United Kingdom | Recruiting |
| Aberdeen Royal Infirmary, NHS Grampian | Aberdeen, United Kingdom | Recruiting |
| Belfast City Hospital, Belfast Health and Social Care Trust | Belfast, United Kingdom | Withdrawn |
| Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust | Birmingham, United Kingdom | Recruiting |
| Bristol Haematology & Oncology Centre, University Hospitals Bristol & Weston NHS Foundation Trust | Bristol, United Kingdom | Active Not Recruiting |
| Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust | Cambridge, United Kingdom | Recruiting |
| Velindre Cancer Centre, Velindre University NHS Trust | Cardiff, United Kingdom | Recruiting |
| Western General Hospital, NHS Lothian | Edinburgh, United Kingdom | Withdrawn |
| Beatson West of Scotland Cancer Centre, NHS Greater Glasgow & Clyde | Glasgow, United Kingdom | Withdrawn |
| Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust | Hull, United Kingdom | Recruiting |
| St James's University Hospital, Leeds Teaching Hospitals NHS Trust | Leeds, United Kingdom | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05629702